All Systems

NextSeq 550Dx

Molecular Diagnostics
Molecular Diagnostics

Advances in genetic analysis are revolutionizing the practice of medicine. Take advantage of these advancements in your lab with the NextSeq 550Dx System.
Expanding Clinical Assay Menu
Expanding Clinical Assay Menu

Gain access to a robust IVD pipeline in development by Illumina.
Compare NextSeq 550Dx and MiSeqDx
Compare the NextSeq 550Dx and the MiSeqDx systems

Both systems deliver the consistency and reliability of a clinical instrument. Learn how these solutions differ to find the right system for your clinical lab.

Flexibility of Dual Operating Modes

Work within a regulated sequencing workflow for developing diagnotic tests and leveraging future NGS IVD tests in the pipeline, while retaining the flexibility to work in a research environment and use the full range of Illumina sequencing methods for a wide range of applications.

Next: Consistency of a Clinical Instrument

Consistency of a Clinical Instrument

The instrument and sequencing reagents are all regulated by the FDA, developed under design control principles, manufactured under Current Good Manufacturing Practices (cGMPs), and verified for consistent assay performance.

Next: Design Your Own NGS Assays for Use on the NextSeq 550Dx System

Design Your Own NGS Assays for Use on the NextSeq 550Dx System

Paired with the TruSeq Custom Amplicon Kit Dx library preparation kit and the NextSeq 550Dx Reagent Kit, the NextSeq 550Dx is part of an IVD development toolkit that enables clinical labs to design clinical assays with regulated components*.

Next: Flexibility of Dual Operating Modes
  1.  
  2.  
  3.  

Workflow

 
Prep

Benefit from a pipeline of IVD tests in development or develop your own.

 
Sequence

Automated sequencing generates data in less than 35 hours.

 
Analyze

The selected analysis initiates automatically and delivers results in a few hours.

See NextSeq 550Dx Application-Specific Workflows

System Specifications

≥90 Gb
output range

≥300 million
reads per run

2 × 150 bp
max read length
View All NextSeq 550Dx Specifications
Interested in receiving newsletters, case studies, and information from Illumina based on your area of interest? Sign up now.

IVD development and testing on the NextSeq 550Dx System*

The TruSeq Custom Amplicon Kit Dx and the NextSeq 550Dx High Output Reagent Kit are IVD reagents and consumables that work together to provide a flexible toolkit for developing and performing diagnostic tests on the NextSeq 550Dx.
View TruSeq Custom Amplicon Kit Dx View NextSeq 550Dx High Output Reagent Kit

Related Solutions

*Contact your Illumina representative for more information about IVD development partnerships.

Intended Use for the NextSeq 550Dx

United States:
The NextSeq 550Dx instrument is intended for targeted sequencing of DNA libraries from human genomic DNA extracted from peripheral whole blood or formalin-fixed, paraffin-embedded (FFPE) tissue, when used for in vitro diagnostic (IVD) assays performed on the instrument. The NextSeq 550Dx instrument is not intended for whole genome or de novo sequencing. The NextSeq 550Dx instrument is to be used with registered and listed, cleared or approved, IVD reagents and analytical software.

European Union:
The NextSeq 550Dx instrument is intended for sequencing of DNA libraries when used with in vitro diagnostic (IVD) assays performed on the instrument. The NextSeq 550Dx instrument is to be used with specific registered, certified or approved IVD reagents and analytical software.

Innovative technologies

At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this challenge. Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics.

For In Vitro Diagnostic Use (except as specifically noted).

Contact an Illumina representative for regional availability.

© 2021 Illumina, Inc. All rights reserved.

All trademarks are the property of Illumina, Inc. or their respective owners.
For specific trademark information, see www.illumina.com/company/legal.html.